Celdara Medical, LLC today announced that the National Cancer Institute of the National Institutes of Health has awarded a two-year, $2 million Phase II Small Business Innovation Research grant to fund the company’s development of a B cell focused immunotherapy to treat melanoma and other cancers.
Lebanon, NH - The biologic, CM-JG01, targets the previously untapped potential of B cells to induce a potent tumoricidal T-cell response. This project ...
Satisfied Users & 
Approved Press Releases
